Method for optical measurements of tissue to determine disease state or concentration of an analyte

• US 7,167,734 B2
• Filed: 04/13/2001
• Issued: 01/23/2007
• Est. Priority Date: 04/13/2001
• Status: Expired due to Term

• Current Assignee: Abbott Diabetes Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Laboratories Incorporated
• Inventors: Shain, Eric B., Khalil, Omar S., Hanna, Charles F., Kantor, Stanislaw, Yeh, Shu-jen
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US09/834,440
• Publication Number:
  US 20030023151A1
• Time in Patent Office: 2,111 Days
• Field of Search: 600309-310, 600322-324, 600/316, 600/331, 356 39- 42
• US Class Current: 600/310
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/1495 Calibrating or testing of in-vivo probes
• CPC Class Codes: A61B 5/7264 Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems neural networks per se G06N3/00; expert systems per se G06N5/00

Abstract

A method for collecting optical data at two morphologically similar, substantially non-overlapping, and preferably adjacent, areas on the surface of a tissue, while the temperature in each area is being maintained or modulated according to a temperature program. The optical data obtained are inserted into a mathematical relationship, e.g., an algorithm, that can be used to predict a disease state (such as the diabetes mellitus disease state) or the concentration of an analyte for indicating a physical condition (such as blood glucose level). This invention can be used to differentiate between disease status, such as, for example, diabetic and non-diabetic. The method involves the generation of a calibration (or training) set that utilizes the relationship between optical signals emanating from the skin under different thermal stimuli and disease status, e.g., diabetic status, established clinically. This calibration set can be used to predict the disease state of other subjects. Structural changes, as well as circulatory changes, due to a disease state are determined at two morphologically similar, but substantially non-overlapping areas on the surface of human tissue, e.g., the skin of a forearm, with each area being subjected to different temperature modulation programs. In addition to determination of a disease state, this invention can also be used to determine the concentration of an analyte in the tissues. This invention also provides an apparatus for the determination of a disease state, such as diabetes, or concentration of an analyte, such as blood glucose level, by the method of this invention.

Claims

1. A method for the determination of a disease state in a human subject, said method comprising the steps of:

(a) measuring at least one optical property at a first area on a body part of said human subject to obtain a first set of data, said first area being subjected to a first temperature program;

(b) measuring at least one optical property at a second area on said body part to obtain a second set of data, said second area being subjected to a second temperature program, said second temperature program being different from the first temperature program, said second area of said body part being morphologically similar to, adjacent to, but not substantially overlapping with said first area of said body part;

(c) inserting said first set of data and said second set of data into a mathematical relationship to calculate a mathematical output; and

(d) using said mathematical output with a decision rule to determine said disease state of said human subject, wherein said disease state is selected from the group consisting of diabetic state, dermal disease state, neoplasmic disease state, and vascular disease state.

2. The method of claim 1, wherein said optical properties are measured with light having a wavelength ranging from about 400 nm to about 2000 nm.

3. The method of claim 1, wherein said optical properties are measured by a diffuse reflectance technique.

4. The method of claim 1, wherein measuring steps (a) and (b) are performed simultaneously.

5. The method of claim 1, wherein measuring steps (a) and (b) are performed sequentially.

6. The method of claim 1, wherein said temperature programs employ temperatures ranging from about 10°

C. to about 45°

C.

7. The method of claim 1, wherein said mathematical relationship of step (c) is derived by a method comprising the steps of:

(a) providing a population comprising a sufficient number of human subjects to establish a category selector, said population comprising a first sub-population comprising a sufficient number of human subjects in said disease state and a second sub-population comprising a sufficient number of human subjects not in said disease state;

(b) for each of said number of human subjects in said population;

(1) measuring at least one optical property at a first area on a part of an arm of each of said human subjects to obtain a first set of data, said first area being subjected to a first temperature program;

(2) measuring at least one optical property at a second area on said part of said arm of each of said human subjects to obtain a second set of data, said second area on said part of said arm of each of said human subjects being subjected to a second temperature program, said second temperature program being different from the first temperature program, said second area of said part of said arm of each of said human subjects being morphologically similar to, adjacent to, but not substantially overlapping with said first area of said part of said arm of each of said human subjects; and

(c) establishing a mathematical relationship between (i) said optical properties of said first set of data and said second set of data and

(ii) said disease state.